Floatz logo

CARMUSTINE

Central Nervous System Vasculitis

Fred Hutchinson Cancer CenterSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Central Nervous System Vasculitis cohort.

Asset / SponsorPhaseRating
Cytosin-Arabinosid
Fred Hutchinson Cancer Center
Phase 2CCC
Evomela
Fred Hutchinson Cancer Center
Phase 2CCC
PREDNISONE TABLETS
Fred Hutchinson Cancer Center
Phase 2CCC
Anti-Thymoglobulin, Rabbit
Fred Hutchinson Cancer Center
Phase 2CCC
ETOPOSIDE
Fred Hutchinson Cancer Center
Phase 2CCC

Same molecule, other indications

CARMUSTINE is also rated in:

plasma cell myelomaDormant
BBB
Indicative ·
74 / 100
View asset →
Hodgkins lymphomaDormant
BBB
Indicative ·
74 / 100
View asset →
B-cell non-Hodgkin lymphomaDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →